Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age
Clinical trial NCT01999842 · COMPLETED
Trial details
- NCT number
- NCT01999842
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-25
- Primary completion
- 2014-02-01
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.